Back

Association between frailty and heart failure incident after acute coronary syndrome

25 April 2024 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke Secondary Prevention Open Access ESC Preventive Cardiology 2024 European Association of Preventive Cardiology (EAPC)

About the speaker

Photo
Mr Kensuke Ueno

Kitasato University Graduate School of Medical Sciences, Sagamihara (Japan)

5 More presentations in this session

Presentation thumbnail
In hospital outcomes of patients with Takotsubo cardiomyopathy and coronary artery vasospasm, insights from a 9 year US retrospective analysis
Doctor K. Inestroza (Rochester, US)
Abstract Slides
Presentation thumbnail
The long-term prognosis of unrecognized myocardial infarction in women and men from the general population
Ms J. Van Oortmerssen (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
In-hospital dynamics of trimethylamine N-oxide (TMAO) predicts major adverse cardiovascular events in patients with acute myocardial infarction
Doctor A. Aleksova (Trieste, IT)
Abstract Slides
Presentation thumbnail
Trends in antithrombotic treatment after cryptogenic stroke and prior transcatheter patent foramen ovale closure.
Doctor A. Apostolos (London, GB)
Abstract Slides
Presentation thumbnail
Impact of a myocardial infarction emergency management network on population 28-day myocardial infarction case-fatality trends 2008-2019
Doctor I. Subirana (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
Assessing and managing cardiovascular risk in patients with acute cardiac syndromes and stroke

The Event

Event poster

ESC Preventive Cardiology 2024

25 April 2024 16:15 CET
You may be interested in
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
thumbnail
Congress Presentation
Optimal medical therapy for primary prevention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources